NCT02609113

Brief Summary

The purpose of this research study is to investigate if magnet therapy is effective as an alternative therapy for CTS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2016

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

January 16, 2018

Completed
Last Updated

September 10, 2018

Status Verified

August 1, 2018

Enrollment Period

1.2 years

First QC Date

November 13, 2015

Results QC Date

November 10, 2017

Last Update Submit

August 10, 2018

Conditions

Keywords

Carpal Tunnel Syndrome

Outcome Measures

Primary Outcomes (1)

  • Change in Boston Carpal Tunnel Questionnaire (BCTQ) Score at 6 Weeks

    Patient reported outcome measure of symptom severity and functional status. Is made of the Symptom severity scale (11 items) score 1 to 5 where lower numbers denotes better outcomes; and the Functional status scale (8 items) score 1 to 5 where lower numbers denotes better outcomes. Total score 1- 95 where lower numbers denotes better outcomes.

    Baseline and 6 weeks

Secondary Outcomes (3)

  • Change in Echogenicity (Hyper or Hypo) on the Median Nerve Ultrasound at 6 Weeks

    Baseline and 6 weeks

  • Change in Cross-sectional Area as Measured in mm2 on Median Nerve Ultrasound at 6 Weeks

    Baseline and 6 weeks

  • Change in Vascularity (Normal or Abnormal) as Measured on Median Nerve Ultrasound at 6 Weeks

    Baseline and 6 weeks

Study Arms (2)

Strong Magnetic Wristband

ACTIVE COMPARATOR

Magnetic wristband of 1,795 Gauss strength

Device: Strong Magnetic Wristband

Weaker Magnetic Wristband

PLACEBO COMPARATOR

Magnetic wristband of 5 Gauss strength.

Device: Weaker Magnetic Wristband

Interventions

Strong Magnetic Wristband
Weaker Magnetic Wristband

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of mild to moderate Carpal Tunnel Syndrome by history, clinical exam and Electromyography (EMG) study.
  • ≥ 18 years

You may not qualify if:

  • Current use of magnets as therapy for Carpal Tunnel Syndrome
  • Known allergy to silicone
  • Unwillingness to wear wristband for 6 weeks
  • Patients who have devices that may be affected by exposure to magnets such as vagal nerve stimulator, pacemaker or insulin pump.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Health

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Limitations and Caveats

Limitations of the study that could contribute to the lack of measurable change include a short duration, small sample size, and inefficacy of magnet therapy in relation to neurodiagnostic measures.

Results Point of Contact

Title
Vanessa Baute, MD
Organization
Wake Forest Baptist Health

Study Officials

  • Vanessa Baute, MD

    Wake ForestUBMC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2015

First Posted

November 20, 2015

Study Start

August 1, 2015

Primary Completion

October 21, 2016

Study Completion

October 21, 2016

Last Updated

September 10, 2018

Results First Posted

January 16, 2018

Record last verified: 2018-08

Locations